Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Reuters NewMedia - November 18, 2008
While the U.S.-based group noted that Lesotho was one of the first countries to implement a mass HIV testing drive, it said the drive was ineffective.
A report compiled with the AIDS and Rights Alliance for Southern Africa (ARASA), an alliance of non-governmental organisations, said the campaign launched in 2005 which aimed to test 1.3 million people was underfunded and had tested only 25,000 by August 2007.
It also said the Know Your Status (KYS) programme failed to take enough rights-related steps to ensure confidentiality.
"The administrative failures also meant that the program was unable to adequately safeguard people's rights," said ARASA's Michaela Clayton.
Lesotho is struggling with a raging HIV/AIDS crisis that is thought to have infected about one third of adults in the country of 1.8 million people. Life expectancy is 35 years for men and 38 for women.
Sub-Saharan Africa has the highest HIV rates in the world. More than two-thirds of people with HIV live in this region, even though it is home to only 13 percent of the world's population, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). Most of them are not aware of their status.
"Community-based HIV testing programs have real potential for reaching people who are otherwise unlikely to test," said Joseph Amon, director of the HIV/AIDS and human rights program at Human Rights Watch.
"It sounds like a simple approach, but for these programs to be truly successful, they must provide counseling, ensure confidentiality, and link people to HIV prevention and treatment services ..."
(Reporting by Michael Georgy; Editing by Charles Dick)
081118
RE081118
Copyright © 2008 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .